Vivo Capital, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 64 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.4%.

Quarter-by-quarter ownership
Vivo Capital, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2024$55,847,712
-16.8%
3,972,0990.0%5.16%
-2.1%
Q1 2024$67,088,752
+16.0%
3,972,099
-3.0%
5.27%
+11.3%
Q4 2023$57,841,563
+37.1%
4,096,4280.0%4.74%
+2.4%
Q3 2023$42,193,208
-33.1%
4,096,428
+7.0%
4.62%
+6.1%
Q2 2023$63,111,429
+83.2%
3,829,577
+1.8%
4.36%
+82.2%
Q1 2023$34,454,772
+174628.8%
3,761,438
+36.6%
2.39%
+5.3%
Q4 2022$19,719
-99.9%
2,754,095
-6.2%
2.27%
+39.7%
Q3 2022$14,715,000
+105.3%
2,937,0930.0%1.62%
+125.7%
Q2 2022$7,167,000
-64.3%
2,937,0930.0%0.72%
-47.9%
Q1 2022$20,060,000
-15.5%
2,937,0930.0%1.38%
-3.5%
Q4 2021$23,732,000
-17.6%
2,937,0930.0%1.43%
+10.8%
Q3 2021$28,784,000
+45.6%
2,937,0930.0%1.29%
+50.9%
Q2 2021$19,767,000
-25.6%
2,937,0930.0%0.86%
-8.3%
Q1 2021$26,551,000
+12.7%
2,937,093
-16.7%
0.93%
-11.2%
Q4 2020$23,554,000
+32.5%
3,526,0930.0%1.05%
+2.3%
Q3 2020$17,772,000
-37.6%
3,526,0930.0%1.03%
-49.7%
Q2 2020$28,491,000
+0.4%
3,526,093
-1.4%
2.04%
-20.6%
Q1 2020$28,389,0003,575,4242.57%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 600,000$8,436,0005.68%
Vivo Capital, LLC 3,972,099$55,847,7125.16%
Tri Locum Partners LP 1,189,518$16,724,6234.23%
Knott David M Jr 333,000$4,6821.87%
MPM BioImpact LLC 783,242$11,012,3831.71%
SCHULHOFF & CO INC 137,000$1,926,2200.87%
1620 INVESTMENT ADVISORS, INC. 1,000$14,0600.01%
Ameritas Investment Partners, Inc. 9,055$127,3130.00%
HUNTINGTON NATIONAL BANK 1$160.00%
CWM, LLC 99$10.00%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders